OPC-67683

delamanid · Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OPC-67683, covering 2007-03-07 to 2021-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) [Phase 2]

See pricing